PROCEPT BioRobotics is a surgical robotics company enabling better patient care by developing solutions to treat prostate disease. With an initial focus on benign prostatic hyperplasia (BPH), the company has developed Aquablation therapy, a novel procedure for the removal of prostate tissue. The company’s first product, the AquaBeam System, leverages Aquablation technology, combining multi-dimensional imaging, heat-free waterjet ablation, and autonomous robotics. This minimally invasive surgical option safely and effectively treats BPH independent of prostate anatomy or surgeon experience. The AquaBeam System is currently for investigational use only in the U.S. and is not marketed for sale. The AquaBeam System is commercially available in Canada, Australia, New Zealand and select European markets.
Brands: AQUABEAM® System for Aquablation therapy